FDA-approved Therapies for Geographic Atrophy

Opinion
Video

An expert retina specialist discusses the recent FDA-approved treatments for geographic atrophy (GA) that slow disease progression and highlights key factors to consider before starting treatment.

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
Related Content
Eyestem reports promising phase 1 trial results in patients with geographic atrophy

Eyestem reports promising phase 1 trial results in patients with geographic atrophy

Martin David Harp
April 14th 2025
Article
Spotlighting telemedicine in the year of a pandemic

Spotlighting telemedicine in the year of a pandemic

Alex Delaney-Gesing
October 19th 2020
Podcast
Seville, Spain, and the Giralda of Seville, in June 2018. Image credit: ©Julián Maldonado – stock.adobe.com

The Congress on Controversies in Ophthalmology (COPHy) highlights debates in surgical, medical retina

Hattie Hayes
April 4th 2025
Article
FDA and EMA approvals in retina this month

FDA and EMA approvals in retina this month

Sydney M Crago
March 30th 2025
Article
Character Biosciences secures $93 million series B financing round

Character Biosciences secures $93 million series B financing round

Martin David Harp
March 26th 2025
Article
Investigators highlight the risk of misdiagnosing geographic atrophy

Investigators highlight the risk of misdiagnosing geographic atrophy

Lynda Charters
March 20th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.